@article{301d3eddebbd4b1897032bf65fc8413e,
title = "Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials",
keywords = "anticoagulation, rivaroxaban, apixaban, venous thromboembolism, ACUTE VENOUS THROMBOEMBOLISM, RANDOMIZED CONTROLLED-TRIALS, VITAMIN-K ANTAGONISTS, ORAL ANTICOAGULANTS, DOUBLE-BLIND, OPEN-LABEL, METAANALYSIS, CANCER, RIVAROXABAN, DABIGATRAN",
author = "Jan Beyer-Westendorf and Lensing, {Anthonie W. A.} and Roopen Arya and Henri Bounameaux and Cohen, {Alexander T.} and Wells, {Philip S.} and Saskia Middeldorp and Peter Verhamme and Rodney Hughes and Nils Kucher and Pap, {Akos F.} and Mila Trajanovic and Prins, {Martin H.} and Paolo Prandoni and Weitz, {Jeffrey I.}",
year = "2017",
month = jan,
doi = "10.1016/j.thromres.2016.11.014",
language = "English",
volume = "149",
pages = "29--37",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Science",
}